VLP THE VACCINES COMPANY (VLPbio)

PRRSV (Porcine Reproductive and Respiratory Syndrome Virus

VLPbio is applying its Ch-VLP technology to develop vaccine prototypes against PRRSV. In vivo tests in pigs are clearly demonstrating the induction of either specific neutralizing or cellular responses to the virus after vaccination.

Infectious Diseases

4R&D

Spain